Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Survival and Disease-Free Survival by Breast Density and Phenotype in Interval Breast Cancers.

Sala M, Domingo L, Louro J, Torá-Rocamora I, Baré M, Ferrer J, Carmona-Garcia MC, Barata T, Román M, Macià F, Castells X; CAMISS Study Group.

Cancer Epidemiol Biomarkers Prev. 2018 Aug;27(8):908-916. doi: 10.1158/1055-9965.EPI-17-0995. Epub 2018 May 31.

PMID:
29853482
2.

Descriptive epidemiology of primary malignant and non-malignant central nervous tumors in Spain: Results from the Girona Cancer Registry (1994-2013).

Fuentes-Raspall R, Solans M, Roca-Barceló A, Vilardell L, Puigdemont M, Del Barco S, Comas R, García-Velasco A, Astudillo A, Carmona-Garcia MC, Marcos-Gragera R.

Cancer Epidemiol. 2017 Oct;50(Pt A):1-8. doi: 10.1016/j.canep.2017.07.005. Epub 2017 Jul 21.

PMID:
28738268
3.

Trends in net survival from rectal cancer in six European Latin countries: results from the SUDCAN population-based study.

Lepage C, Bossard N, Dejardin O, Carmona-Garcia MC, Manfredi S, Faivre J; GRELL EUROCARE-5 Working Group.

Eur J Cancer Prev. 2017 Jan;26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study:S48-S55. doi: 10.1097/CEJ.0000000000000305.

PMID:
28005605
4.

Correlation between mutational status and survival and second cancer risk assessment in patients with gastrointestinal stromal tumors: a population-based study.

Rubió-Casadevall J, Borràs JL, Carmona-García MC, Ameijide A, Gonzalez-Vidal A, Ortiz MR, Bosch R, Riu F, Parada D, Martí E, Miró J, Sirvent JJ, Galceran J, Marcos-Gragera R.

World J Surg Oncol. 2015 Feb 13;13:47. doi: 10.1186/s12957-015-0474-0.

Supplemental Content

Loading ...
Support Center